Online citations, reference lists, and bibliographies.
← Back to Search

MALIGN PLEVRAL MEZOTELYOMA AYIRICI TANISI VE PROGNOZUNDA 18F-FDG PET/BT’NİN ROLÜ

D. Şimşek, S. Kuyumcu, Y. Şanlı, Z. Özkan, B. Ozkan, C. Turkmen, Emine Dilek Yılmazbayhan, A. Mudun
Published 2019 ·

Cite This
Download PDF
Analyze on Scholarcy
Share
Yöntem: Konvansiyonel BT’de saptanan diffüz ya da nodüler plevral kalınlaşma nedeniyle 18F-FDG PET/BT çekilen 58 hasta retrospektif olarak incelendi. 18F-FDG PET/BT taramaları, maksimum standartlaştırılmış uptake değeri (SUVmax) kullanılarak görsel ve yarı kantitatif olarak değerlendirildi. Pozitif/negatif tutulum ayrımında eşik değeri olarak mediastinal kan havuzu SUVmax değerleri kullanıldı. 18F-FDG PET/BT bulguları, histopatolojik bulgular ve sağkalım verileri ile karşılaştırıldı. Hastalar klinik ve radyolojik olarak takip edildi.
This paper references
10.1097/RLI.0b013e3181817b3d
Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results
C. Plathow (2008)
10.1097/MNM.0b013e328310b3ba
Dual time point FDG PET for evaluation of malignant pleural mesothelioma
Y. Yamamoto (2009)
10.1510/icvts.2010.255901
Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
S. Sharif (2011)
10.1097/JTO.0b013e3181c0a7ff
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease: An Observational Pilot Study
H. Yildirim (2009)
10.1055/s-2008-1039314
The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
A. Orki (2009)
PET for the evaluation of pleural thickening observed on CT.
H. Kramer (2004)
10.1136/thoraxjnl-2014-206054
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
10.1007/s00259-018-4056-6
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients
E. Incerti (2018)
10.1016/j.acra.2013.09.015
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
G. Treglia (2014)
10.1038/bjc.2014.478
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
A. Linton (2014)
PET-CT in pleural mesothelioma İstanbul Tıp Fakültesi Dergisi •
(2019)
10.1097/JTO.0b013e318211127a
Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma: A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid Mesothelioma
Kyuichi Kadota (2011)
10.1097/00008469-200506000-00001
Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988–2000: a population-based study
G. Gorini (2005)
10.1016/j.ejrad.2016.11.019
Prognostic value of pretreatment volume-based quantitative 18F-FDG PET/CT parameters in patients with malignant pleural mesothelioma.
K. Kitajima (2017)
10.1148/RG.241035058
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
Z. Wang (2004)
Prognostic value of 18 F-FDG PET/ CT in patients with malignant pleural mesothelioma
S Lee (2009)
10.1016/j.remn.2011.06.002
The role of FDG PET-CT in differential diagnosis of pleural pathologies.
U. Elboğa (2012)
10.3892/or.2011.1520
Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Y. Abe (2012)
10.1016/j.lungcan.2015.07.011
Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.
S. Armato (2015)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)



Semantic Scholar Logo Some data provided by SemanticScholar